Evidence map›Paper›PMID 40270896›Full record

ArticleJournal of cardiology cases2025

Rescue from sudden ventricular tachycardia and fibrillation using wearable cardioverter-defibrillator in male late-onset Fabry disease patient.

Toraaki Okuyama, Eiko Fukuro, Kenichi Tokutake, Masahisa Kobayashi, Hiroshi Kobayashi, Michihiro Yoshimura, Kenichi Hongo

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of cardiology cases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Toraaki OkuyamaDivision of Cardiology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
Eiko FukuroDivision of Cardiology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
Kenichi TokutakeDivision of Cardiology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
Masahisa KobayashiDepartment of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan.
Hiroshi KobayashiDivision of Gene Therapy, Research Center for Molecular Sciences, The Jikei University School of Medicine, Tokyo, Japan.
Michihiro YoshimuraDivision of Cardiology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
Kenichi HongoDivision of Cardiology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fabry disease is an important secondary cardiomyopathy characterized by the accumulation of glycosphingolipids due to a pathogenic mutation in the Learning objective: In Fabry disease, lethal ventricular arrhythmia is an important cause of sudden death. Ventricular tachycardia and fibrillation during enzyme replacement therapy have not been reported. Furthermore, secondary prevention of lethal ventricular arrhythmia using a wearable cardioverter-defibrillator has not been reported in Fabry disease. Therefore, this case report has implications for the possible incidence and prevention of lethal ventricular arrhythmias in patients with Fabry disease.

Indexed as

Fabry diseaseImplantable cardioverter-defibrillatorSudden cardiac deathVentricular arrhythmiaWearable cardioverter-defibrillator

Identifiers

PMID40270896
PMCPMC12013757

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.